Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Twelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...

Investors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...

Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...

Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...

Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...

Foreign institutional investors have divested approximately $53 billion from Indian equities since September 2024, leading to significant o...

Foreign investors have divested $53 billion from Indian equities since late 2024, leading to underperformance against emerging markets. Dom...

Indian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...

Domestic equity benchmarks ended marginally higher after four sessions of losses, supported by gains in metal, energy and consumer stocks. ...

Indian markets saw volatile trading on Thursday, closing nearly unchanged despite positive signals. Several companies including SBI, Titan,...

Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...

Sun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...

The Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...

To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...

Torrent Pharma signals a potential uptrend. The stock recently emerged from a nine-month consolidation. Experts suggest a buying opportunit...

Sequoia-backed Curatio's top three brands - Tedibar, a baby soap, Atogla, a skin moisturiser for babies and Spoo, a baby shampoo - contribu...